Project
Illumina Body Map 2
Navigation
Downloads
Results for MNT_HEY1_HEY2
Z-value: 1.24
Motif logo
Transcription factors associated with MNT_HEY1_HEY2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MNT
|
ENSG00000070444.10 | MAX network transcriptional repressor |
|
HEY1
|
ENSG00000164683.12 | hes related family bHLH transcription factor with YRPW motif 1 |
|
HEY2
|
ENSG00000135547.4 | hes related family bHLH transcription factor with YRPW motif 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HEY1 | hg19_v2_chr8_-_80680078_80680101 | 0.19 | 3.1e-01 | Click! |
| MNT | hg19_v2_chr17_-_2304365_2304412 | 0.18 | 3.3e-01 | Click! |
| HEY2 | hg19_v2_chr6_+_126070726_126070768 | 0.05 | 8.0e-01 | Click! |
Activity profile of MNT_HEY1_HEY2 motif
Sorted Z-values of MNT_HEY1_HEY2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_-_241520525 | 6.99 |
ENST00000366565.1
|
RGS7
|
regulator of G-protein signaling 7 |
| chr6_+_73331918 | 6.85 |
ENST00000402622.2
ENST00000355635.3 ENST00000403813.2 ENST00000414165.2 |
KCNQ5
|
potassium voltage-gated channel, KQT-like subfamily, member 5 |
| chr15_+_75118888 | 5.13 |
ENST00000395018.4
|
CPLX3
|
complexin 3 |
| chr1_-_241520385 | 5.12 |
ENST00000366564.1
|
RGS7
|
regulator of G-protein signaling 7 |
| chr1_+_150254936 | 4.65 |
ENST00000447007.1
ENST00000369095.1 ENST00000369094.1 |
C1orf51
|
chromosome 1 open reading frame 51 |
| chr1_-_26233423 | 4.10 |
ENST00000357865.2
|
STMN1
|
stathmin 1 |
| chrX_+_152224766 | 4.00 |
ENST00000370265.4
ENST00000447306.1 |
PNMA3
|
paraneoplastic Ma antigen 3 |
| chr1_-_26232951 | 3.71 |
ENST00000426559.2
ENST00000455785.2 |
STMN1
|
stathmin 1 |
| chrX_-_20134713 | 3.61 |
ENST00000452324.3
|
MAP7D2
|
MAP7 domain containing 2 |
| chr1_-_26232522 | 3.55 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
| chr11_+_125774258 | 3.55 |
ENST00000263576.6
|
DDX25
|
DEAD (Asp-Glu-Ala-Asp) box helicase 25 |
| chr1_+_202995611 | 3.50 |
ENST00000367240.2
|
PPFIA4
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
| chrX_-_13956497 | 3.47 |
ENST00000398361.3
|
GPM6B
|
glycoprotein M6B |
| chr7_+_36429409 | 3.47 |
ENST00000265748.2
|
ANLN
|
anillin, actin binding protein |
| chr16_+_6533380 | 3.20 |
ENST00000552089.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chrX_-_13956737 | 3.19 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
| chr4_+_128651530 | 3.17 |
ENST00000281154.4
|
SLC25A31
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 |
| chrX_-_20134990 | 3.07 |
ENST00000379651.3
ENST00000443379.3 ENST00000379643.5 |
MAP7D2
|
MAP7 domain containing 2 |
| chr7_+_36429424 | 3.00 |
ENST00000396068.2
|
ANLN
|
anillin, actin binding protein |
| chr7_+_97361388 | 2.92 |
ENST00000350485.4
ENST00000346867.4 |
TAC1
|
tachykinin, precursor 1 |
| chr22_+_21319396 | 2.87 |
ENST00000399167.2
ENST00000399163.2 ENST00000441376.2 |
AIFM3
|
apoptosis-inducing factor, mitochondrion-associated, 3 |
| chr2_-_50574856 | 2.78 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
| chr16_-_755726 | 2.70 |
ENST00000324361.5
|
FBXL16
|
F-box and leucine-rich repeat protein 16 |
| chr1_+_210111534 | 2.66 |
ENST00000422431.1
ENST00000534859.1 ENST00000399639.2 ENST00000537238.1 |
SYT14
|
synaptotagmin XIV |
| chr3_+_10857885 | 2.65 |
ENST00000254488.2
ENST00000454147.1 |
SLC6A11
|
solute carrier family 6 (neurotransmitter transporter), member 11 |
| chrX_+_153524024 | 2.56 |
ENST00000369915.3
ENST00000217905.7 |
TKTL1
|
transketolase-like 1 |
| chr7_+_97361218 | 2.55 |
ENST00000319273.5
|
TAC1
|
tachykinin, precursor 1 |
| chr5_+_55033845 | 2.49 |
ENST00000353507.5
ENST00000514278.2 ENST00000505374.1 ENST00000506511.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
| chr13_-_36788718 | 2.43 |
ENST00000317764.6
ENST00000379881.3 |
SOHLH2
|
spermatogenesis and oogenesis specific basic helix-loop-helix 2 |
| chr11_+_125774362 | 2.43 |
ENST00000530414.1
ENST00000530129.2 |
DDX25
|
DEAD (Asp-Glu-Ala-Asp) box helicase 25 |
| chr1_+_150229554 | 2.40 |
ENST00000369111.4
|
CA14
|
carbonic anhydrase XIV |
| chr3_-_42306248 | 2.39 |
ENST00000334681.5
|
CCK
|
cholecystokinin |
| chr17_-_32906388 | 2.37 |
ENST00000357754.1
|
C17orf102
|
chromosome 17 open reading frame 102 |
| chr16_-_755819 | 2.31 |
ENST00000397621.1
|
FBXL16
|
F-box and leucine-rich repeat protein 16 |
| chr15_-_83316254 | 2.31 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr11_-_45307817 | 2.31 |
ENST00000020926.3
|
SYT13
|
synaptotagmin XIII |
| chr8_+_75896849 | 2.28 |
ENST00000520277.1
|
CRISPLD1
|
cysteine-rich secretory protein LCCL domain containing 1 |
| chr2_-_27486951 | 2.26 |
ENST00000432351.1
|
SLC30A3
|
solute carrier family 30 (zinc transporter), member 3 |
| chr2_+_17721937 | 2.24 |
ENST00000451533.1
|
VSNL1
|
visinin-like 1 |
| chr16_+_333152 | 2.22 |
ENST00000219406.6
ENST00000404312.1 ENST00000456379.1 |
PDIA2
|
protein disulfide isomerase family A, member 2 |
| chr7_+_43152212 | 2.21 |
ENST00000453890.1
|
HECW1
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
| chrX_-_102319092 | 2.21 |
ENST00000372728.3
|
BEX1
|
brain expressed, X-linked 1 |
| chr20_+_44657845 | 2.20 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
| chr2_-_11810284 | 2.19 |
ENST00000306928.5
|
NTSR2
|
neurotensin receptor 2 |
| chr7_-_44365020 | 2.14 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr19_+_4304585 | 2.13 |
ENST00000221856.6
|
FSD1
|
fibronectin type III and SPRY domain containing 1 |
| chr8_-_54755459 | 2.12 |
ENST00000524234.1
ENST00000521275.1 ENST00000396774.2 |
ATP6V1H
|
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H |
| chr3_+_50712672 | 2.10 |
ENST00000266037.9
|
DOCK3
|
dedicator of cytokinesis 3 |
| chr19_+_4304632 | 2.09 |
ENST00000597590.1
|
FSD1
|
fibronectin type III and SPRY domain containing 1 |
| chr2_+_17721230 | 2.07 |
ENST00000457525.1
|
VSNL1
|
visinin-like 1 |
| chr2_+_17721920 | 2.07 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
| chr8_+_35092959 | 2.06 |
ENST00000404895.2
|
UNC5D
|
unc-5 homolog D (C. elegans) |
| chr1_+_11866270 | 2.05 |
ENST00000376497.3
ENST00000376487.3 ENST00000376496.3 |
CLCN6
|
chloride channel, voltage-sensitive 6 |
| chr1_-_166944652 | 2.02 |
ENST00000528703.1
ENST00000525740.1 ENST00000529387.1 ENST00000469934.2 ENST00000529071.1 ENST00000526687.1 |
ILDR2
|
immunoglobulin-like domain containing receptor 2 |
| chr4_-_6202247 | 2.02 |
ENST00000409021.3
ENST00000409371.3 |
JAKMIP1
|
janus kinase and microtubule interacting protein 1 |
| chr1_+_210111570 | 2.00 |
ENST00000367019.1
ENST00000472886.1 |
SYT14
|
synaptotagmin XIV |
| chr1_+_11866207 | 1.98 |
ENST00000312413.6
ENST00000346436.6 |
CLCN6
|
chloride channel, voltage-sensitive 6 |
| chr2_-_170219037 | 1.96 |
ENST00000443831.1
|
LRP2
|
low density lipoprotein receptor-related protein 2 |
| chr2_-_170219079 | 1.95 |
ENST00000263816.3
|
LRP2
|
low density lipoprotein receptor-related protein 2 |
| chr7_-_44365216 | 1.91 |
ENST00000358707.3
ENST00000457475.1 ENST00000440254.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr19_-_49016847 | 1.90 |
ENST00000598924.1
|
CTC-273B12.10
|
CTC-273B12.10 |
| chr19_-_3869012 | 1.90 |
ENST00000592398.1
ENST00000262961.4 ENST00000439086.2 |
ZFR2
|
zinc finger RNA binding protein 2 |
| chr11_-_88799113 | 1.87 |
ENST00000393294.3
|
GRM5
|
glutamate receptor, metabotropic 5 |
| chr16_+_84002234 | 1.87 |
ENST00000305202.4
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2 |
| chr4_+_37245799 | 1.84 |
ENST00000309447.5
|
KIAA1239
|
KIAA1239 |
| chr16_+_89642120 | 1.84 |
ENST00000268720.5
ENST00000319518.8 |
CPNE7
|
copine VII |
| chr2_-_97652290 | 1.82 |
ENST00000327896.3
|
FAM178B
|
family with sequence similarity 178, member B |
| chr22_+_40390930 | 1.82 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
| chr17_+_30813576 | 1.78 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
| chr8_-_75233563 | 1.76 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
| chr6_-_33385655 | 1.74 |
ENST00000440279.3
ENST00000607266.1 |
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr7_+_43152191 | 1.74 |
ENST00000395891.2
|
HECW1
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
| chr22_+_18593097 | 1.73 |
ENST00000426208.1
|
TUBA8
|
tubulin, alpha 8 |
| chrX_+_21392553 | 1.72 |
ENST00000279451.4
|
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr22_-_36903101 | 1.69 |
ENST00000397224.4
|
FOXRED2
|
FAD-dependent oxidoreductase domain containing 2 |
| chr12_-_45270077 | 1.69 |
ENST00000551601.1
ENST00000549027.1 ENST00000452445.2 |
NELL2
|
NEL-like 2 (chicken) |
| chr18_+_43913919 | 1.69 |
ENST00000587853.1
|
RNF165
|
ring finger protein 165 |
| chr4_+_176987131 | 1.69 |
ENST00000280190.4
|
WDR17
|
WD repeat domain 17 |
| chr14_+_92789498 | 1.68 |
ENST00000531433.1
|
SLC24A4
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 |
| chr15_-_83316711 | 1.68 |
ENST00000568128.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr8_-_109095862 | 1.65 |
ENST00000522333.1
ENST00000276659.5 |
RSPO2
|
R-spondin 2 |
| chr9_-_139922726 | 1.65 |
ENST00000265662.5
ENST00000371605.3 |
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr19_-_51142540 | 1.64 |
ENST00000598997.1
|
SYT3
|
synaptotagmin III |
| chr2_-_50201327 | 1.64 |
ENST00000412315.1
|
NRXN1
|
neurexin 1 |
| chr12_-_45270151 | 1.63 |
ENST00000429094.2
|
NELL2
|
NEL-like 2 (chicken) |
| chr6_-_33385823 | 1.63 |
ENST00000494751.1
ENST00000374496.3 |
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr20_+_44657807 | 1.63 |
ENST00000372315.1
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
| chr4_-_6202291 | 1.62 |
ENST00000282924.5
|
JAKMIP1
|
janus kinase and microtubule interacting protein 1 |
| chr1_-_166944561 | 1.61 |
ENST00000271417.3
|
ILDR2
|
immunoglobulin-like domain containing receptor 2 |
| chr7_-_150675372 | 1.61 |
ENST00000262186.5
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
| chr5_+_176237478 | 1.60 |
ENST00000329542.4
|
UNC5A
|
unc-5 homolog A (C. elegans) |
| chr1_-_113498616 | 1.60 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr9_+_103235365 | 1.58 |
ENST00000374879.4
|
TMEFF1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
| chr19_-_49016418 | 1.57 |
ENST00000270238.3
|
LMTK3
|
lemur tyrosine kinase 3 |
| chr16_-_4588762 | 1.57 |
ENST00000562334.1
ENST00000562579.1 ENST00000567695.1 ENST00000563507.1 |
CDIP1
|
cell death-inducing p53 target 1 |
| chr16_-_4588822 | 1.56 |
ENST00000564828.1
|
CDIP1
|
cell death-inducing p53 target 1 |
| chr8_+_109455830 | 1.55 |
ENST00000524143.1
|
EMC2
|
ER membrane protein complex subunit 2 |
| chr8_-_54755789 | 1.55 |
ENST00000359530.2
|
ATP6V1H
|
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H |
| chr13_+_112721913 | 1.53 |
ENST00000330949.1
|
SOX1
|
SRY (sex determining region Y)-box 1 |
| chr1_+_166958504 | 1.53 |
ENST00000447624.1
|
MAEL
|
maelstrom spermatogenic transposon silencer |
| chr8_-_109095897 | 1.52 |
ENST00000378439.2
|
RSPO2
|
R-spondin 2 |
| chr4_+_172734548 | 1.51 |
ENST00000506823.1
|
GALNTL6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
| chr17_-_57184260 | 1.50 |
ENST00000376149.3
ENST00000393066.3 |
TRIM37
|
tripartite motif containing 37 |
| chr2_-_232328867 | 1.49 |
ENST00000453992.1
ENST00000417652.1 ENST00000454824.1 |
NCL
|
nucleolin |
| chr17_-_57184064 | 1.49 |
ENST00000262294.7
|
TRIM37
|
tripartite motif containing 37 |
| chr9_-_23821842 | 1.49 |
ENST00000544538.1
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
| chr12_+_50355647 | 1.49 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
| chr4_+_176986978 | 1.49 |
ENST00000508596.1
ENST00000393643.2 |
WDR17
|
WD repeat domain 17 |
| chr11_-_17498348 | 1.46 |
ENST00000389817.3
ENST00000302539.4 |
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
| chrX_+_21392529 | 1.46 |
ENST00000425654.2
ENST00000543067.1 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr14_+_93799556 | 1.46 |
ENST00000256339.4
|
UNC79
|
unc-79 homolog (C. elegans) |
| chr17_-_77179487 | 1.44 |
ENST00000580508.1
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
| chr4_-_46996424 | 1.43 |
ENST00000264318.3
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
| chr12_+_117176090 | 1.42 |
ENST00000257575.4
ENST00000407967.3 ENST00000392549.2 |
RNFT2
|
ring finger protein, transmembrane 2 |
| chr8_+_109455845 | 1.42 |
ENST00000220853.3
|
EMC2
|
ER membrane protein complex subunit 2 |
| chr2_+_115919049 | 1.42 |
ENST00000393147.2
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional) |
| chr7_-_37382683 | 1.40 |
ENST00000455879.1
|
ELMO1
|
engulfment and cell motility 1 |
| chr8_+_75896731 | 1.40 |
ENST00000262207.4
|
CRISPLD1
|
cysteine-rich secretory protein LCCL domain containing 1 |
| chr3_+_147127142 | 1.40 |
ENST00000282928.4
|
ZIC1
|
Zic family member 1 |
| chr6_+_160221293 | 1.37 |
ENST00000610273.1
ENST00000392167.3 |
PNLDC1
|
poly(A)-specific ribonuclease (PARN)-like domain containing 1 |
| chr19_-_17799008 | 1.37 |
ENST00000519716.2
|
UNC13A
|
unc-13 homolog A (C. elegans) |
| chr8_+_67405794 | 1.37 |
ENST00000522977.1
ENST00000480005.1 |
C8orf46
|
chromosome 8 open reading frame 46 |
| chr6_-_33385854 | 1.37 |
ENST00000488478.1
|
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr6_-_33385902 | 1.37 |
ENST00000374500.5
|
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr22_-_36903069 | 1.36 |
ENST00000216187.6
ENST00000423980.1 |
FOXRED2
|
FAD-dependent oxidoreductase domain containing 2 |
| chr1_+_50513686 | 1.35 |
ENST00000448907.2
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr3_+_132757215 | 1.35 |
ENST00000321871.6
ENST00000393130.3 ENST00000514894.1 ENST00000512662.1 |
TMEM108
|
transmembrane protein 108 |
| chr4_-_5891918 | 1.34 |
ENST00000512574.1
|
CRMP1
|
collapsin response mediator protein 1 |
| chr12_+_58013693 | 1.34 |
ENST00000320442.4
ENST00000379218.2 |
SLC26A10
|
solute carrier family 26, member 10 |
| chr11_+_65479702 | 1.34 |
ENST00000530446.1
ENST00000534104.1 ENST00000530605.1 ENST00000528198.1 ENST00000531880.1 ENST00000534650.1 |
KAT5
|
K(lysine) acetyltransferase 5 |
| chrX_+_102469997 | 1.33 |
ENST00000372695.5
ENST00000372691.3 |
BEX4
|
brain expressed, X-linked 4 |
| chr12_+_117176113 | 1.33 |
ENST00000319176.7
|
RNFT2
|
ring finger protein, transmembrane 2 |
| chr19_-_46974741 | 1.32 |
ENST00000313683.10
ENST00000602246.1 |
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
| chr8_+_67405755 | 1.31 |
ENST00000521495.1
|
C8orf46
|
chromosome 8 open reading frame 46 |
| chr18_-_4455283 | 1.30 |
ENST00000315677.3
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
| chr1_-_31712401 | 1.30 |
ENST00000373736.2
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
| chr18_+_32073253 | 1.29 |
ENST00000283365.9
ENST00000596745.1 ENST00000315456.6 |
DTNA
|
dystrobrevin, alpha |
| chr1_+_110162448 | 1.29 |
ENST00000342115.4
ENST00000469039.2 ENST00000474459.1 ENST00000528667.1 |
AMPD2
|
adenosine monophosphate deaminase 2 |
| chr3_-_45883558 | 1.28 |
ENST00000445698.1
ENST00000296135.6 |
LZTFL1
|
leucine zipper transcription factor-like 1 |
| chr6_-_163834852 | 1.27 |
ENST00000604200.1
|
CAHM
|
colon adenocarcinoma hypermethylated (non-protein coding) |
| chrX_+_10126488 | 1.27 |
ENST00000380829.1
ENST00000421085.2 ENST00000454850.1 |
CLCN4
|
chloride channel, voltage-sensitive 4 |
| chr16_+_66914264 | 1.26 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
| chr15_-_83315874 | 1.26 |
ENST00000569257.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr6_-_33385870 | 1.26 |
ENST00000488034.1
|
CUTA
|
cutA divalent cation tolerance homolog (E. coli) |
| chr22_+_18593446 | 1.25 |
ENST00000316027.6
|
TUBA8
|
tubulin, alpha 8 |
| chr4_-_168155300 | 1.24 |
ENST00000541637.1
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr22_-_50523843 | 1.23 |
ENST00000535444.1
ENST00000431262.2 |
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
| chr22_-_42310570 | 1.23 |
ENST00000457093.1
|
SHISA8
|
shisa family member 8 |
| chr19_-_46974664 | 1.23 |
ENST00000438932.2
|
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
| chr7_+_94536898 | 1.23 |
ENST00000433360.1
ENST00000340694.4 ENST00000424654.1 |
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
| chr9_+_140772226 | 1.22 |
ENST00000277551.2
ENST00000371372.1 ENST00000277549.5 ENST00000371363.1 ENST00000371357.1 ENST00000371355.4 |
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
| chr22_+_18593507 | 1.21 |
ENST00000330423.3
|
TUBA8
|
tubulin, alpha 8 |
| chr4_-_77819002 | 1.21 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr19_-_40896081 | 1.20 |
ENST00000291823.2
|
HIPK4
|
homeodomain interacting protein kinase 4 |
| chr10_-_50970322 | 1.20 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
| chr22_-_50523688 | 1.19 |
ENST00000450140.2
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
| chr9_-_139922631 | 1.19 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr22_-_50523807 | 1.19 |
ENST00000442311.1
ENST00000538737.1 |
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
| chr11_+_105480793 | 1.18 |
ENST00000282499.5
ENST00000393127.2 ENST00000527669.1 |
GRIA4
|
glutamate receptor, ionotropic, AMPA 4 |
| chr11_+_121322832 | 1.18 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr18_-_4455260 | 1.18 |
ENST00000581527.1
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
| chr8_+_85095497 | 1.18 |
ENST00000522455.1
ENST00000521695.1 |
RALYL
|
RALY RNA binding protein-like |
| chr1_+_154193325 | 1.17 |
ENST00000428931.1
ENST00000441890.1 ENST00000271877.7 ENST00000412596.1 ENST00000368504.1 ENST00000437652.1 |
UBAP2L
|
ubiquitin associated protein 2-like |
| chr19_-_49137762 | 1.15 |
ENST00000593500.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
| chr3_-_178789220 | 1.15 |
ENST00000414084.1
|
ZMAT3
|
zinc finger, matrin-type 3 |
| chr19_+_4304685 | 1.14 |
ENST00000601006.1
|
FSD1
|
fibronectin type III and SPRY domain containing 1 |
| chr16_+_330581 | 1.13 |
ENST00000219409.3
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
| chr14_-_77737543 | 1.13 |
ENST00000298352.4
|
NGB
|
neuroglobin |
| chr9_+_129987488 | 1.13 |
ENST00000446764.1
|
GARNL3
|
GTPase activating Rap/RanGAP domain-like 3 |
| chr6_+_87865262 | 1.12 |
ENST00000369577.3
ENST00000518845.1 ENST00000339907.4 ENST00000496806.2 |
ZNF292
|
zinc finger protein 292 |
| chr19_-_49137790 | 1.11 |
ENST00000599385.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
| chr13_-_100624012 | 1.11 |
ENST00000267294.4
|
ZIC5
|
Zic family member 5 |
| chr3_-_149688971 | 1.11 |
ENST00000498307.1
ENST00000489155.1 |
PFN2
|
profilin 2 |
| chr1_-_154531095 | 1.11 |
ENST00000292211.4
|
UBE2Q1
|
ubiquitin-conjugating enzyme E2Q family member 1 |
| chr12_-_91348949 | 1.10 |
ENST00000358859.2
|
CCER1
|
coiled-coil glutamate-rich protein 1 |
| chr5_+_55033872 | 1.09 |
ENST00000515709.1
ENST00000506848.1 ENST00000514679.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
| chr13_-_51417812 | 1.09 |
ENST00000504404.1
|
DLEU7
|
deleted in lymphocytic leukemia, 7 |
| chr7_-_37382360 | 1.08 |
ENST00000455119.1
|
ELMO1
|
engulfment and cell motility 1 |
| chr12_+_4918342 | 1.08 |
ENST00000280684.3
ENST00000433855.1 |
KCNA6
|
potassium voltage-gated channel, shaker-related subfamily, member 6 |
| chr10_-_75634219 | 1.07 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr22_-_50523760 | 1.07 |
ENST00000395876.2
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
| chr16_+_1031762 | 1.06 |
ENST00000293894.3
|
SOX8
|
SRY (sex determining region Y)-box 8 |
| chr2_-_220118631 | 1.06 |
ENST00000248437.4
|
TUBA4A
|
tubulin, alpha 4a |
| chr15_-_83316087 | 1.06 |
ENST00000568757.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr17_-_49337392 | 1.05 |
ENST00000376381.2
ENST00000586178.1 |
MBTD1
|
mbt domain containing 1 |
| chr1_-_113498943 | 1.05 |
ENST00000369626.3
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr16_-_30022735 | 1.04 |
ENST00000564944.1
|
DOC2A
|
double C2-like domains, alpha |
| chr10_-_98273668 | 1.04 |
ENST00000357947.3
|
TLL2
|
tolloid-like 2 |
| chr1_-_166135952 | 1.04 |
ENST00000354422.3
|
FAM78B
|
family with sequence similarity 78, member B |
| chr15_+_32322709 | 1.02 |
ENST00000455693.2
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
| chr7_+_72742178 | 1.02 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
| chr6_+_13182751 | 1.02 |
ENST00000415087.1
|
PHACTR1
|
phosphatase and actin regulator 1 |
| chr15_-_73925651 | 1.02 |
ENST00000545878.1
ENST00000287226.8 ENST00000345330.4 |
NPTN
|
neuroplastin |
| chr1_-_230513367 | 1.02 |
ENST00000321327.2
ENST00000525115.1 |
PGBD5
|
piggyBac transposable element derived 5 |
| chr11_+_18343800 | 1.02 |
ENST00000453096.2
|
GTF2H1
|
general transcription factor IIH, polypeptide 1, 62kDa |
| chr15_+_32322685 | 1.01 |
ENST00000454250.3
ENST00000306901.3 |
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
| chr22_-_38577782 | 1.01 |
ENST00000430886.1
ENST00000332509.3 ENST00000447598.2 ENST00000435484.1 ENST00000402064.1 ENST00000436218.1 |
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent) |
| chr8_-_95908902 | 1.01 |
ENST00000520509.1
|
CCNE2
|
cyclin E2 |
| chr14_+_60386853 | 1.01 |
ENST00000570145.1
|
LRRC9
|
leucine rich repeat containing 9 |
| chr7_-_50132801 | 1.00 |
ENST00000419417.1
|
ZPBP
|
zona pellucida binding protein |
Network of associatons between targets according to the STRING database.
First level regulatory network of MNT_HEY1_HEY2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 6.5 | GO:0000921 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 1.8 | 5.5 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 1.6 | 11.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 1.3 | 3.8 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 1.1 | 3.2 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.9 | 2.6 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.8 | 3.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.8 | 8.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.7 | 4.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.6 | 1.8 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.6 | 1.7 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.5 | 1.6 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.5 | 2.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.5 | 4.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.5 | 1.9 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.5 | 1.9 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.5 | 0.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 | 1.3 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.4 | 1.3 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.4 | 11.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.4 | 2.8 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 | 1.2 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.4 | 1.6 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.4 | 6.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.4 | 1.2 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.4 | 1.1 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.4 | 1.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.4 | 1.1 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 0.4 | 1.1 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.3 | 0.7 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 0.3 | 1.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.3 | 1.3 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.3 | 1.0 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.3 | 1.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.3 | 0.9 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.3 | 1.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.3 | 1.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 | 0.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.3 | 2.6 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.3 | 2.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 0.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.3 | 1.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.3 | 6.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 | 4.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.3 | 0.8 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
| 0.3 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.3 | 2.0 | GO:0050893 | sensory processing(GO:0050893) |
| 0.2 | 0.7 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 | 0.7 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.2 | 0.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.2 | 0.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 0.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 | 0.2 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.2 | 0.7 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.2 | 2.4 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.2 | 1.7 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.2 | 0.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 | 1.0 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.2 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.2 | 5.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.2 | 1.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.2 | 1.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.2 | 1.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.2 | 1.4 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.2 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.2 | 3.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 0.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.2 | 0.7 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.2 | 0.7 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.2 | 0.5 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.2 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 0.7 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.2 | 0.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 0.2 | 1.1 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.2 | 0.6 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 | 1.1 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.2 | 0.8 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.2 | 3.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.8 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.1 | 1.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.1 | 0.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 | 0.6 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
| 0.1 | 0.7 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.1 | 0.7 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.1 | 2.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.7 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.1 | 0.4 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.1 | 1.5 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 2.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.4 | GO:0007497 | posterior midgut development(GO:0007497) |
| 0.1 | 5.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 0.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) Golgi to lysosome transport(GO:0090160) |
| 0.1 | 0.7 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.1 | 0.4 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.1 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 1.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.1 | 1.6 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 | 0.5 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 | 1.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.1 | 1.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 1.9 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.1 | 11.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 | 0.4 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.1 | 2.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.6 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 | 0.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of anagen(GO:0051885) |
| 0.1 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 1.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 0.7 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.1 | 8.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.1 | 1.5 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 2.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 | 0.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.1 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 | 0.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.3 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.1 | 0.8 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 1.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.1 | 3.8 | GO:0010038 | response to metal ion(GO:0010038) |
| 0.1 | 0.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 3.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 2.6 | GO:0015669 | gas transport(GO:0015669) |
| 0.1 | 0.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.1 | 1.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 0.9 | GO:1990034 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export from cell(GO:1990034) |
| 0.1 | 1.0 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 1.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 3.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 1.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 4.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 | 1.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 | 1.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 0.2 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.1 | 1.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.1 | 0.3 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.1 | 0.2 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
| 0.1 | 1.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 1.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 1.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 1.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 | 0.4 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.2 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.1 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 3.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 1.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.5 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.7 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 1.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 0.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 | 0.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.1 | 4.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 1.4 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 1.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.4 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 | 0.3 | GO:0061074 | regulation of neural retina development(GO:0061074) |
| 0.1 | 1.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.4 | GO:0051643 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 0.5 | GO:0046959 | habituation(GO:0046959) |
| 0.1 | 1.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 1.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.6 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 | 0.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 | 3.0 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 3.0 | GO:0060384 | innervation(GO:0060384) |
| 0.1 | 0.2 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 1.1 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 | 2.7 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.2 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.1 | 1.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 1.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.7 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.2 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.1 | 0.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 | 1.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 0.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.1 | 0.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 2.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.6 | GO:0009636 | response to toxic substance(GO:0009636) |
| 0.0 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.0 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 | 0.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 | 0.6 | GO:0015816 | glycine transport(GO:0015816) |
| 0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.0 | 1.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 | 0.1 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.0 | 0.9 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.0 | 2.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.0 | 1.6 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.0 | 1.2 | GO:0048265 | response to pain(GO:0048265) |
| 0.0 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
| 0.0 | 0.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 2.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 | 0.2 | GO:0097178 | ruffle organization(GO:0031529) ruffle assembly(GO:0097178) |
| 0.0 | 0.2 | GO:2000672 | response to sorbitol(GO:0072708) cellular response to sorbitol(GO:0072709) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 | 0.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 | 0.2 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.0 | 0.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 1.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.1 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 | 0.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.0 | 0.1 | GO:0061054 | forebrain anterior/posterior pattern specification(GO:0021797) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) positive regulation of dermatome development(GO:0061184) |
| 0.0 | 1.3 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.0 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.0 | 0.9 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 0.0 | 0.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.0 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.0 | 4.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.4 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
| 0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.0 | 0.4 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
| 0.0 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 | 0.1 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 | 0.2 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 | 1.7 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 | 0.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 0.2 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 1.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.0 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.0 | 0.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.0 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.0 | 2.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 1.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.0 | 0.2 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 | 0.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.0 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.0 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 1.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 0.2 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.0 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.0 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.0 | 2.8 | GO:0006839 | mitochondrial transport(GO:0006839) |
| 0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 | 0.3 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 0.5 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.7 | GO:0060271 | cilium morphogenesis(GO:0060271) |
| 0.0 | 0.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 0.1 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.0 | 0.0 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.3 | GO:0007507 | heart development(GO:0007507) |
| 0.0 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 | 0.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.0 | 0.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 | 0.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.0 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.0 | 0.8 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.0 | 0.6 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.0 | 0.2 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 | 0.8 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 3.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.0 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.0 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.0 | 0.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.7 | GO:0043065 | positive regulation of apoptotic process(GO:0043065) |
| 0.0 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 0.0 | 0.1 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.0 | 0.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 | 0.3 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 | 0.5 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 | 0.0 | GO:0098727 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.0 | 0.0 | GO:0008585 | female gonad development(GO:0008585) development of primary female sexual characteristics(GO:0046545) female sex differentiation(GO:0046660) |
| 0.0 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.0 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.4 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.0 | 0.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 0.6 | GO:0060004 | reflex(GO:0060004) |
| 0.0 | 0.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.0 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.0 | 0.2 | GO:1990834 | response to odorant(GO:1990834) |
| 0.0 | 0.3 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 | 0.6 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.0 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.0 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 | 0.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.0 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.0 | 0.4 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.0 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.8 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.0 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 | 0.2 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
| 0.0 | 0.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.0 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.2 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 | 0.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.0 | 1.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:0019343 | cysteine biosynthetic process from serine(GO:0006535) cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.0 | 0.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.0 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.0 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 | 0.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.0 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.0 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.0 | 0.5 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.0 | 0.2 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.2 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
| 0.0 | 0.2 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.0 | 0.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.3 | GO:0007129 | synapsis(GO:0007129) |
| 0.0 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.0 | 0.1 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.0 | 0.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 1.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.0 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 | 0.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 2.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 | 0.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 | 0.0 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.0 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 0.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.0 | 0.1 | GO:0008643 | carbohydrate transport(GO:0008643) |
| 0.0 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 1.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.0 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.1 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.0 | 1.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 1.1 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.1 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 0.1 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.0 | 2.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.2 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.0 | 0.5 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 0.0 | 0.2 | GO:0009584 | detection of visible light(GO:0009584) |
| 0.0 | 0.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.0 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.0 | 0.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.0 | 0.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.1 | GO:0042262 | DNA protection(GO:0042262) |
| 0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |